Brain Scientific Balance Sheet Health
Financial Health criteria checks 2/6
Brain Scientific has a total shareholder equity of $4.3M and total debt of $2.8M, which brings its debt-to-equity ratio to 64.2%. Its total assets and total liabilities are $11.7M and $7.4M respectively.
Key information
64.2%
Debt to equity ratio
US$2.77m
Debt
Interest coverage ratio | n/a |
Cash | US$747.71k |
Equity | US$4.32m |
Total liabilities | US$7.43m |
Total assets | US$11.74m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BRSF's short term assets ($1.3M) do not cover its short term liabilities ($7.4M).
Long Term Liabilities: BRSF's short term assets ($1.3M) exceed its long term liabilities ($7.4K).
Debt to Equity History and Analysis
Debt Level: BRSF's net debt to equity ratio (46.9%) is considered high.
Reducing Debt: BRSF had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if BRSF has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if BRSF has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.